COMMUNIQUÉS West-GlobeNewswire

-
Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Dividend Stock Previously Distributed by Sorrento to its Stockholders as a Dividend to April 14, 2025
31/01/2025 -
Interpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2024 Financial and Business Results
31/01/2025 -
ARCPOINT ANNOUNCES C$800,000 NON-BROKERED PRIVATE PLACEMENT
31/01/2025 -
Outlook Therapeutics® Appoints Faisal G. Sukhtian as Chairman of the Board of Directors
31/01/2025 -
Fractyl Health Announces Increased Focus on Groundbreaking Revita® Weight Maintenance and Rejuva® Pancreatic Gene Therapy Programs with Potential to Deliver Key Clinical Milestones Across Multiple Studies in 2025
31/01/2025 -
NewGen Announces Reverse Stock Split
31/01/2025 -
Retrieve Medical Expands into Ambulatory Care with New Client Engagement
31/01/2025 -
Immutep Quarterly Activities Report Q2 FY25
31/01/2025 -
Erasca to Present at the Guggenheim Securities SMID Cap Biotech Conference
31/01/2025 -
Rezolute to Participate in the Guggenheim SMID Cap Biotech Conference
31/01/2025 -
SeaStar Medical Announces $6 Million Registered Direct Offering Priced At-the-Market
31/01/2025 -
CervoMed Provides Update on Neflamapimod DLB Program as Part of Presentation at the 8th International Lewy Body Dementia Conference
31/01/2025 -
Y-mAbs Presents Translational Pharmacokinetics of GD2-SADA from Pretargeted RIT Platform at the SNMMI Mid-Winter and ACNM Annual Meeting
31/01/2025 -
Quipt Home Medical Responds to Kanen Wealth Management
31/01/2025 -
23andMe Launches New Genetic Report on Osteoporosis
31/01/2025 -
SAB BIO to Participate in Upcoming Investor Conferences
31/01/2025 -
Axsome Therapeutics Hosts SYMBRAVO® FDA Approval Virtual Investor Event with Expert Thought Leader
31/01/2025 -
OKYO Pharma Announces Chairman and CEO Acquire Shares
31/01/2025 -
Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union
31/01/2025
Pages